GlassScriptPhysician profile
Aaron B Pearl
NPI 1730154048
$9,900.14
in general payments reported to CMS, 2019-2025
31 companies · $5,956 in 2025
The $5,956 reported for 2025 was more than what 94% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $683 · 2020: $210 · 2021: $599 · 2022: $1,042 · 2023: $464 · 2024: $945 · 2025: $5,956.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,203 · Travel and Lodging: $2,993 · Consulting Fee: $1,170.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,202.87 |
| Travel and Lodging | $2,992.68 |
| Consulting Fee | $1,170.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $2,601.53 | 2019-2025 | Kerecis Surgiclose, Kerecis Graftguide, Kerecis Omega3 Marigen |
| Convatec INC. | $2,032.32 | 2024-2025 | |
| Paratek Pharmaceuticals, INC. | $1,429.07 | 2021-2025 | Nuzyra |
| Smith+Nephew, INC. | $549.00 | 2019-2025 | Renasys Touch, Pico, Pico 7 |
| Horizon Therapeutics Plc | $443.96 | 2019-2023 | Krystexxa |
| Melinta Therapeutics, LLC | $338.52 | 2019-2024 | Kimyrsa |
| Cardiovascular Systems INC. | $216.03 | 2021 | |
| Abbott Laboratories | $179.35 | 2021-2024 | Diamondback Peripheral |
| Heron Therapeutics, INC. | $172.38 | 2022 | |
| Nevro Corp. | $168.30 | 2022-2024 | Senza |
| Bioventus LLC | $162.44 | 2022 | |
| Integra Lifesciences Corporation | $159.83 | 2019-2020 | |
| Sanara Medtech INC. | $149.87 | 2024 | Celleraterx |
| Merck Sharp & Dohme LLC | $136.12 | 2019 | |
| Nuo Therapeutics | $132.15 | 2025 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $125.27 | 2022-2025 | Symplicity G3, Inceptiv |
| Globus Medical, INC. | $118.01 | 2025 | Senza |
| Vertex Pharmaceuticals Incorporated | $116.93 | 2025 | |
| Triad Life Sciences INC. | $112.04 | 2022 | |
| Terumo Medical Corporation | $97.85 | 2021-2022 | |
| Organogenesis INC. | $83.85 | 2019-2023 | Puraply |
| Amniox Medical, INC. | $71.95 | 2019 | |
| Curonix LLC | $67.59 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Osiris Therapeutics INC. | $55.32 | 2019 | |
| Averitas Pharma INC. | $27.73 | 2025 | Qutenza |
| Rikco International, LLC | $27.53 | 2019 | |
| Tactile Systems Technology INC | $27.33 | 2019-2020 | |
| Trice Medical, INC. | $26.65 | 2022 | |
| Fidia Pharma USA INC. | $24.65 | 2019 | |
| Amgen INC. | $23.78 | 2024 | Krystexxa |
| Zimmer Biomet Holdings, INC. | $22.79 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aaron Pearl listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.